Damián Alvarez-Paggi

Damián Alvarez-Paggi is a prominent Argentine researcher specializing in nanobioengineering. He is known for his work at the Conicet and as the founder and CEO of Eureka Nanobioengineering. Recently, he was in the news for being the first author of a significant study published in The Lancet, which identified multiple phenotypes of bronchopulmonary dysplasia in premature infants, aiming to improve diagnostic accuracy and treatment strategies.